Edoxaban, an oral anticoagulant, was equally or more effective than warfarin in reducing the risk of stroke and blood clots for patients after heart valve replacement surgery, according to preliminary ...
The control unit delivers enhanced connectivity, real-time diagnostics for valves in food and beverage applications CHARLOTTE, N.C., Nov. 18, 2024 /PRNewswire/ -- SPX FLOW, a global leader in ...
New York, New York-- (Newsfile Corp. - November 18, 2024) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation ...